CURRENT TUBERCULOSIS A IN HIV-INFECTED PATIENTS
Keywords:
Key words: phthisiology, tuberculosis, HIV infection, Mycobacterium tuberculosis, immunosuppression, clinical manifestations, treatment.Abstract
Summary:
Tuberculosis is widespread in all regions of the world. According to WHO, in
2016, 476,774 people with tuberculosis had a positive HIV status, which accounted for
7.5% of all reported cases. In 2016, more than 374,000 people living with HIV died
from tuberculosis worldwide (WHO, 2017). In recent years, the In the Russian
Federation, there is a steady increase in the incidence of tuberculosis in patients with
HIV infection. According to the Federal Tuberculosis Monitoring Center, the number
of people living with HIV infection has doubled. The article provides an overview of
the epidemic indicators of tuberculosis and HIV infection in Russia. Problems of
diagnosis of tuberculosis in combination withcoinfection, as well as new laboratory
and immunological methods used today in the world and domestic practice to
determine tuberculosis infection.
References
Literature
1. Alekseeva L. P. Features of detection, clinical course and treatment of patients with
tuberculosis and HIV infection. Abstract of the thesis. ... Candidate of Medical
Sciences, Moscow, 2008; 43 p.
2. Belyakova N. V. Improvement of tuberculosis prevention in HIV-infected patients
in penitentiary institutions. Abstract of the thesis. ... Candidate of Medical
Sciences, Moscow, 2011; 26 p.
3. Borovitsky V. S. Roentgenological picture of pulmonary tuberculosis combined
with HIV infection in patients in a medical institution of the Federal Penitentiary
Service. – 2018; 1: 66–7.
4. Zimina V. N. Improving the diagnosis and effectiveness of tuberculosis treatment
in patients with HIV infection with various degrees of immunosuppression.
Abstract of the thesis. ... Doctor of Medical Sciences, Moscow, 2012; 45 p.
5. Ivanov A. K., Shevyreva E. V., Skrynnik N. A. et al. Treatment of patients with
tuberculosis and HIV infection in a day hospital of an antitubercular dispensary.
Proceedings of the X Annual All-Russian Congress on Infectious Diseases with
International participation, Moscow, 2018; p. 82.
6. Oblokulov A.A., Oblokulov A.R., Ergashov M.M. Clinical and laboratory criteria
for spontaneous bacterial peritonitis in liver cirrhosis of viral etiology. Central
Asian journal of medical and natural sciences Volume 03, Issue 03, may-jun 2022
172-177. ISSN: 2660-4159.
7. Abdulloev Mukhriddin Ziyodulloevich. (2023). Modern Therapy of Viral
Hepatitis. Texas Journal of Medical Science, 26, 66–69. Retrieved from
https://www.zienjournals.com/index.php/tjms/article/view/4636 9. Oblokulov R.
8. A., Abdulloev M. Z. To Study the Effectiveness of Direct-Antiviral Drug in the
Treatment of Chronic Viral Hepatitis C, Your Act //Web of Scholars:
Multidimensional Research Journal. – 2022. – Т. 1. – №. 5. – С. 201-206.
9. Ziyodulloyevich A. M. IN CHRONIC VIRAL HEPATITIS AND CIRRHOSIS OF
THE LIVER, THE STUDY OF CYTOKINE LEVELS //BARQARORLIK VA
YETAKCHI TADQIQOTLAR ONLAYN ILMIY JURNALI. – 2022. – Т. 2. – №.
12. - pp. 784-787.
10. Ziyodulloevich A. M. EFFICIENCY OF ETIOTROPIC TREATMENT IN
CHRONIC VIRAL HEPATITIS //Galaxy International Interdisciplinary Research
Journal. – 2023. – Т. 11. – №. 4. – С. 450-454.
11. Ziyodullayevich A. M. Studies on the Determination of Cytokines in Patients with
Chronic Hepatitis C with Criglobulinemia //American Journal of Pediatric
Medicine and Health Sciences (2993-2149). – 2023. – Т. 1. – №. 10. – С. 487-495.
12. Salina T. Yu., Morozova T. I. Clinical manifestations and effectiveness of
treatment of patients with coinfection with tuberculosis / HIV infection and
hepatitis / / Tuberculosis and lung diseases. – 2017; 95 (9): 25-9. DOI:
10.21292/2075-1230- 2017-95-9-25-29.
13. Galkin V. G., Elenkina Zh. V., Epifantseva N. A. et al. TB/HIV in the Russian
Federation. Epidemiology, features of clinical manifestations and treatment results.
Edited by S. A. Sterlikov / Moscow: RIO TSNIIOIZ, 2017; 52 p.
14. Fomenkova N. V. Clinical and laboratory characteristics of HIV infection in
combination with various forms of tuberculosis. Dis. ... candidate of Medical
Sciences. St. Petersburg, 2004; 140 p.
15. Frolova O. P., Kravchenko A. B., Martynov A. A. et al. Organization of TB care
for patients with HIV infection. Manual for doctors / M., Tver: OOO "Publishing
House "Triada", 2007; 120 p.
16. Shchelkanova A. I. Features of the clinical course and effectiveness of tuberculosis
chemotherapy in HIV-infected individuals. Abstract of the thesis.. дис ...
Candidate of Medical Sciences, Moscow, 2003; 24 p.
17. Beyrer C., Wirtz A., O'Hara G. et al. The expanding epidemic of HIV-1 in the
Russian Federation // PLoS Med. – 2017; 14 (11): e1002462. https://doi.
org/10.1371/journal.pmed.1002462.
18. Ellis P., Martin W., Dodd P. CD4 count and tuberculosis risk in HIV-positive
adults not on ART: a systematic review and meta-analysis // Peer J. – 2017; 5:
e4165. DOI: 10.7717/peerj.4165. 19. Isaakidis P., Casas E., Das M. et al.
Treatment outcomes for HIV and MDR-TB co-infected adults and children:
systematic review and meta-analysis. // Int. J. Tuberc. Lung Dis. – 2015;
19. (8): 969–78. http://dx.doi.org/10.5588/ ijtld.15.0123.
20. Kistana J., Lahera F., Otwombea K. et al. Pulmonary TB: varying radiological
presentations in individuals with HIV in Soweto, South Africa // Trans. R. Soc.
Trop. Med. Hyg. – 2017; 111: 132–6. DOI: 10.1093/trstmh/trx028.
21. Lawn S., Myer L., Bekker L. et al. Tuberculosis-associated immune reconstitution
disease: incidence, risk factors and impact in an antiretroviral treatment service in
South Africa // AIDS. – 2007; 21: 335–41.
22. Mahtab S., Coetzee D. Influence of HIV and other risk factors on tuberculosis // S.
Afr. Med. J. – 2017; 107 (5): 428–34. DOI: 10.7196/SAMJ.2017. v107i5.11271.
23. Murray J., Sonnenberg P., Shearer S. et al. Human immunodeficiency virus and
the outcome of treatment for new and recurrent pulmonary tuberculosis in African
patients // Am. J. Respir. Crit. Care. Med. – 1999; 159 (3): 733–40.
24. Nglazi M., Bekker L.-G., Wood R. et al. The impact of HIV status and
antiretroviral treatment on TB treatment outcomes of new tuberculosis patients
attending collocated TB and ART services in South Africa: a retrospective cohort
study // BMC Infect. Dis. – 2015; 15: 536. DOI: 10.1186/s12879-015-1275-3.
25. Satti H., McLaughlin M., Hedt-Gauthier B. et al. Outcomes of Multidrug Resistant
Tuberculosis Treatment with Early Initiation of Antiretroviral Therapy for HIV
Co-Infected Patients in Lesotho // PLoS One. – 2012; 7 (10): 46943.
26. Shivacoti R., Sharma D., Mamoon G. et al. Association of HIV infection with
extrapulmonary tuberculosis: a systemic review //Infection. – 2017; 1: 11–21. doi:
10.1007/s15010-016-0960-5
27. Sinshaw Y., Alemu Sh., Fekadu A., Gizachew M. Successful TB treatment
outcome and its associated factors among TB/HIV co-infected patients attending
Gondar University Referral Hospital, Northwest Ethiopia: an institution based
crosssectional study. // BMC Infectious Diseases. – 2017; 17: e132. DOI 10.1186/
s12879-017-2238-7
28. World Health Organization, Global tuberculosis report 2017. http://www.
who.int/tb/publications/global_report/en/(Accessed 2 August 2017).
